A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type

被引:103
|
作者
Moene, FC
Spinhoven, P
Hoogduin, KAL
van Dyck, R
机构
[1] Psychiat Ctr Albert Schweitzerplaats, De Grote Rivieren Org Mental Hlth, Treatment Unit Convers Disorders, NL-3318 AR Dordrecht, Netherlands
[2] Leiden Univ, Dept Clin Psychol, Leiden, Netherlands
[3] Univ Nijmegen, Dept Clin Psychol & Personal, Nijmegen, Netherlands
[4] Vrije Univ Amsterdam, Dept Psychiat, Amsterdam, Netherlands
关键词
conversion disorder (motor); somatisation disorder; psychogenic motor symptoms; hypnosis; controlled; randomised; clinical trial; treatment outcome; movement disorder;
D O I
10.1159/000049348
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background; The primary aim of this study was threes fold: (1) to examine the additional effects of hypnosis aimed at symptom reduction, using symptom-oriented and expression- and insight-oriented techniques in a comprehensive clinical treatment programme for inpatients with a persistent conversion disorder of the motor type; (2) to assess whether the level of hypnotisability was predictive of treatment outcome, and (3) to explore the efficacy of the total clinical treatment programme. Methods.-The study population consisted of 45 in-patients between 18 and 65 years of age meeting the DSM-III-R criteria for conversion disorder of the motor type or somatisation disorder with motor conversion symptoms. A randomised controlled clinical trial was undertaken. The primary outcome measures were the Video Rating Scale for Motor Conversion Symptoms, the D(isabilities) code items from the International Classification of Impairments, Disabilities and Handicaps and the Symptom Checklist-90. Measures of the credibility of treatment and patient expectations of treatment outcome were used as manipulation checks. Hypnotisability was measured using the Stanford Hypnotic Clinical Scale. Results: Significant treatment results for all outcome measures were found for the total sample. These effects proved to be clinically significant. The use of hypnosis had no additional effect on treatment outcome. Hypnotisability was not predictive of treatment outcome., Conclusion: A comprehensive treatment programme, either with or without hypnosis, can be worthwhile for patients with long-standing conversion symptoms. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:66 / 76
页数:11
相关论文
共 50 条
  • [21] Walking with Diabetes (WW-DIAB) programme a walking programme for Indonesian type 2 diabetes mellitus patients: A pilot randomised controlled trial
    Arovah, Novita Intan
    Kushartanti, Bernadeta Margareta Wara
    Washington, Tracy L.
    Heesch, Kristiann C.
    SAGE OPEN MEDICINE, 2018, 6
  • [22] An informed shared decision making programme for patients with type 2 diabetes in primary care: cluster randomised controlled trial
    Buhse, S.
    Kuniss, N.
    Liethmann, K.
    Mueller, U. A.
    Lehmann, T.
    Muehlhauser, I.
    DIABETOLOGIA, 2017, 60 : S347 - S347
  • [23] An informed shared decision making programme on the prevention of myocardial infarction for patients with type 2 diabetes: randomised, controlled trial
    Buhse, S.
    Muehlhauser, I.
    Heller, T.
    Kasper, J.
    Kuniss, N.
    Mueller, U. A.
    Lehmann, T.
    Lenz, M.
    DIABETOLOGIA, 2015, 58 : S429 - S430
  • [24] Efficacy of a self-management education programme on patients with type 2 diabetes in primary care: A randomised controlled trial
    Gamboa Moreno, Estibaliz
    Mateo-Abad, Maider
    de Retana Garcia, Lourdes Ochoa
    Vrotsou, Kalliopi
    del Campo Pena, Emma
    Sanchez Perez, Alvaro
    Martinez Carazo, Catalina
    Arbonies Ortiz, Juan Carlos
    Rua Portu, M. Angeles
    Pinera Elorriaga, Koldo
    Zenarutzabeitia Pikatza, Amaya
    Urquiza Bengoa, Miren Nekane
    Mendez Sanpedro, Tomas
    Portu, Ana Oses
    Aguirre Sorondodo, Miren Bakarne
    Rotaeche del Campo, Rafael
    PRIMARY CARE DIABETES, 2019, 13 (02) : 122 - 133
  • [25] A randomised controlled trial of an internet-based mentoring programme for type 1 diabetes patients with inadequate glycaemic control
    Suh, S.
    Park, S. M.
    Kim, T.
    Jin, S. M.
    Bae, J. C.
    Hur, K. Y.
    Lee, M. K.
    Kim, J. H.
    DIABETOLOGIA, 2013, 56 : S451 - S451
  • [26] Effect of pharmacogenomic testing on the clinical treatment of patients with depressive disorder: A randomized clinical trial
    Xu, Lei
    Li, Liyin
    Wang, Qiutang
    Pan, Bing
    Zheng, Leilei
    Lin, Zheng
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 359 : 117 - 124
  • [27] Evaluation of the Effectiveness of a Structured Diabetes Education Programme (CHOICE) on Clinical Outcomes for Adolescents with Type 1 Diabetes: A Randomised Controlled Trial
    Coates, Vivien
    Chaney, David
    Bunting, Brendan
    Shorter, Gillian W.
    Shevlin, Mark
    McDougall, Andrea
    Long, Arlene
    JOURNAL OF DIABETES & METABOLISM, 2013, 4 (06)
  • [28] Liraglutide as Additional Treatment to Insulin in Patients with Type 1 Diabetes Mellitus: A Randomized Clinical Trial
    Kuhadiya, Nitesh D.
    Dhindsa, Sandeep
    Makdissi, Antoine
    Ghanim, Husam A.
    Batra, Manav
    Chaudhuri, Ajay
    Hejna, Jeanne
    Green, Kelly
    Bellini, Natalie
    Dandona, Paresh
    DIABETES, 2014, 63 : A250 - A250
  • [29] Liraglutide As Additional Treatment to Insulin in Patients with Type 1 Diabetes Mellitus: A Randomized Clinical Trial
    Kuhadiya, Nitesh D.
    Dhindsa, Sandeep S.
    Mehta, Aditya
    Makdissi, Antoine
    Sandhu, Sartaj
    Ghanim, Husam
    Batra, Manav
    Chaudhuri, Ajay
    Hejna, Jeanne
    Green, Kelly
    Bellini, Natalie
    Dandona, Paresh
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [30] Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial
    Kwee, Caroline M. B.
    Baas, Johanna M. P.
    van der Flier, Febe E.
    Groenink, Lucianne
    Duits, Puck
    Eikelenboom, Merijn
    van der Veen, Date C.
    Moerbeek, Mirjam
    Batelaan, Neeltje M.
    Balkom, Anton J. L. M. van
    Cath, Danielle C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2022, 59 : 58 - 67